Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery.

[1]  P. De Groote,et al.  Antiphospholipid antibodies and the risk of thromboembolic events in valvular heart disease. , 2003, Mayo Clinic proceedings.

[2]  M. Lockshin,et al.  Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of literature, and recommendations. , 2002, The Journal of rheumatology.

[3]  J. Piette,et al.  Antiphospholipid syndrome nephropathy in systemic lupus erythematosus. , 2002, Journal of the American Society of Nephrology : JASN.

[4]  J. Amano,et al.  Mitral stenosis and regurgitation with systemic lupus erythematosus and antiphospholipid antibody syndrome. , 2001, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[5]  M. Amigo.  Prognosis in antiphospholipid syndrome. , 2001, Rheumatic diseases clinics of North America.

[6]  E. DeLong,et al.  Prediction of operative mortality after valve replacement surgery. , 2001, Journal of the American College of Cardiology.

[7]  K. Kodera,et al.  Mitral insufficiency associated with primary antiphospholipid syndrome and chronic renal failure. , 2001, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[8]  C. Mackworth-Young,et al.  Primary Antiphospholipid Syndrome , 2006 .

[9]  R. Cervera.  Recent advances in antiphospholipid antibody-related valvulopathies. , 2000, Journal of autoimmunity.

[10]  W. Edwards,et al.  Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery. , 2000, Mayo Clinic proceedings.

[11]  A. Hishida,et al.  Catastrophic exacerbation of antiphospholipid syndrome after lung adenocarcinoma biopsy. , 2000, The Journal of rheumatology.

[12]  M. Turiel,et al.  Evaluation of cardiac abnormalities and embolic sources in primary antiphospholipid syndrome by transesophageal echocardiography , 2000, Lupus.

[13]  Thomas E. Moritz,et al.  Mild renal failure is associated with adverse outcome after cardiac valve surgery. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  J. Mathew,et al.  Antiphospholipid syndrome and cardiac surgery: management of anticoagulation in two patients. , 2000, Anesthesia and analgesia.

[15]  E. Frenkel,et al.  Antiphospholipid-Thrombosis Syndromes , 1999, Pathophysiology of Haemostasis and Thrombosis.

[16]  G. Hirsch,et al.  Double valve replacement in a patient with anticardiolipin antibody syndrome , 1999, Perfusion.

[17]  R. Manor,et al.  Increased endothelial cell expression of a3β1 integrin in cardiac valvulopathy in the primary (Hughes) and secondary antiphospholipid syndrome , 1999, Lupus.

[18]  H. Ogino,et al.  Aortic valve replacement for aortic regurgitation in a patient with primary antiphospholipid syndrome. , 1999, Japanese circulation journal.

[19]  W A Wilson,et al.  International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. , 1999, Arthritis and rheumatism.

[20]  N. Espinola-Zavaleta,et al.  Echocardiographic evaluation of patients with primary antiphospholipid syndrome. , 1999, American heart journal.

[21]  Y. Shoenfeld,et al.  Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease. , 1999, Clinical and experimental rheumatology.

[22]  G. Sakaguchi,et al.  Aortic valve replacement after previous coronary artery bypass grafting in a patient with antiphospholipid syndrome. , 1998, The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi.

[23]  J. Ilany,et al.  Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. , 1997, Seminars in arthritis and rheumatism.

[24]  T. Abe,et al.  [A case report on mitral valve replacement associated with antiphospholipid syndrome in systemic lupus erythematosus]. , 1997, Kyobu geka. The Japanese journal of thoracic surgery.

[25]  Y. Shoenfeld,et al.  Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. , 1996, Circulation.

[26]  L. Cohn,et al.  Guidelines for reporting morbidity and mortality after cardiac valvular operations. , 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[27]  W. Klein,et al.  [Thrombosis of a prosthetic mitral valve in the anticardiolipin syndrome]. , 2008, Deutsche medizinische Wochenschrift.

[28]  S. Noji,et al.  [Successful surgical treatment of mitral regurgitation associated with anti-phospholipid syndrome and systemic lupus erythematosus]. , 1995, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai.

[29]  E. Harris,et al.  The antiphospholipid syndrome , 1995, Clinical reviews in allergy & immunology.

[30]  M. V. Egurbide-Arberas,et al.  Severe valvular heart disease in a patient with primary antiphospholipid syndrome. , 1994, Lupus.

[31]  R. Cervera,et al.  Cardiac manifestations of the antiphospholipid syndrome. , 1993, Coronary artery disease.

[32]  A. Evangelista,et al.  Valvular Heart Disease in the Primary Antiphospholipid Syndrome , 1992, Annals of Internal Medicine.

[33]  G. Hughes,et al.  The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features , 1989, Medicine.

[34]  L. Cohn,et al.  Guidelines for reporting morbidity and mortality after cardiac valvular operations. , 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[35]  E. Hurley,et al.  Cardiac valve replacement in systemic lupus erythematosus. A review. , 1983, The Journal of thoracic and cardiovascular surgery.